Observe Medical schedules EGM for NOK 10m private placement approval

Observe Medical ASA has announced an extraordinary general meeting (EGM) on 10 October 2025 to approve a private placement that will issue 20,000,000 new shares. This issuance, at a subscription price of NOK 0.50 per share, is expected to raise gross proceeds of NOK 10,000,000. The private placement is conditional on EGM approval of the share capital increase.

The proposed share capital increase of NOK 8,400,000 will be through a cash contribution, deviating from shareholders' preferential rights. The proceeds are earmarked for securing working capital to support product development and scale up production and sales activities. The board emphasizes that the private placement is in the company's and its shareholders' best interest, with the Blystad Group poised to become an attractive shareholder.

Shareholders can attend the EGM physically in Oslo, vote in advance electronically or by mail, or assign a proxy. The deadline for advance votes, proxies, and instructions is 8 October 2025 at 23:59 CEST. The company plans to publish a prospectus around 25 September 2025 related to the listing of these new shares on Euronext Expand.